Abstract
The aim of the review was to systematize the evidence available in the world literature on the influence of the role of microbiota and urinary microbiome on the development of bladder cancer. Given the constant development of medical technologies, patient examination algorithms, an obligate range of diagnostic tools, and the appropriateness of using the latest laboratory techniques are being reviewed.
Highlights
Microbiota / microbiome urine and bladder cancer M.
Рак мочевого пузыря (РМП) был диагностирован у 17 426 пациентов, среди них 13 479 мужчин и 3947 женщин [1].
Уже более 50 лет хорошо известна роль такого паразитарного поражения мочевого пузыря, как шистосомоз (Shistosoma haematobium), в развитии его раковой трансформации.
Summary
Microbiota / microbiome urine and bladder cancer M. Рак мочевого пузыря (РМП) был диагностирован у 17 426 пациентов, среди них 13 479 мужчин и 3947 женщин [1]. Уже более 50 лет хорошо известна роль такого паразитарного поражения мочевого пузыря, как шистосомоз (Shistosoma haematobium), в развитии его раковой трансформации.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
